Respiratory Disorders

June 10, 2025

Dexamethasone vs. prednisone for acute asthma exacerbations

Article: J Pediatr. 2017 Dec:191:190-196.e1. "Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations" Reviewer: Dr. Stewart Kaiser

May 20, 2025

Antibiotic therapy for community-acquired pneumonia

Article:  JAMA Pediatr. 2022 Mar 1;176(3):253-261. "Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial" Reviewer: Dr. Pete Hunter

May 6, 2025

The role of airway clearance treatments in CF patients on modulators

Article:  Lancet Respir Med. 2023 Apr;11(4):329-340. "Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials" Reviewer: Dr. Paola Orozco

March 18, 2025

Caffeine for apnea of prematurity

Article: New England Journal of Medicine. 2006 May 18;354(20):2112-21. "Caffeine therapy for apnea of prematurity" Reviewer: Dr. Parker Weigle 

May 7, 2024

Shorter tuberculosis treatment in children

Article: N Engl J Med.  2022 Mar 10;386(10):911-922. "Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children." Reviewer: Dr. Brenden Stealey

Feb. 27, 2024

Dexamethasone vs. prednisone for acute asthma

Article: J Pediatr. 2017 Dec;191:190-196.e1. Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations Reviewer: Dr. Bailey Clancy

June 13, 2023

SMART: a new strategy in asthma

Article: Chest. 2006 Dec;130(6):1733-43. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma Reviewer: Dr. Cece Gadaga

April 18, 2023

Hydrocortisone to improve survival for extremely premature infants

Article: N Engl J Med. 2022 Mar 24;386(12):1121-1131. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia Reviewer: Dr. Spencer Price

May 17, 2022

Immunotherapy for rhinitis

Article: Am J Rhinol Allergy. Mar-Apr 2014;28(2):131-9. doi: 10.2500/ajra.2014.28.4006. Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis Reviewer: Dr. Janki Patel

Sept. 22, 2020

Nirsevimab for Prevention of RSV

Article: N Engl J Med. 2020 Jul 30;383(5):415-425. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants Reviewer: Dr. Shreeya Chugh